Galapagos, MorphoSys report Phase I data for atopic dermatitis candidate

Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) and MorphoSys AG (Xetra:MOR; Pink:MPSYY) reported pooled data from 25 patients with moderate to severe atopic dermatitis across

Read the full 229 word article

User Sign In